Pneumocystis jiroveci prophylaxis in patients undergoing Bendamustine treatment: the need for a standardized protocol

The decision for PJP prophylaxis depends on a physician's evaluation of multiple variables. The high rate of PJP infection described in this article combined with the known impaired T-cell function post Bendamustine treatment justifies considering all patients for PJP prophylaxis when they rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Abkur, Tarig Mohammed, Saeed, Mamoun, Ahmed, Saad Zeinalabdin, McArthur, Ryan, Leahy, Maeve, O'Leary, Hilary, O'Keeffe, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405313/
https://www.ncbi.nlm.nih.gov/pubmed/25914820
http://dx.doi.org/10.1002/ccr3.195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405313/
https://www.ncbi.nlm.nih.gov/pubmed/25914820
http://dx.doi.org/10.1002/ccr3.195

Ejemplares similares